Prelude Therapeutics Incorporated (PRLD)
NASDAQ: PRLD · Real-Time Price · USD
1.300
+0.412 (46.40%)
At close: Dec 20, 2024, 4:00 PM
1.280
-0.020 (-1.54%)
After-hours: Dec 20, 2024, 7:59 PM EST
Prelude Therapeutics Ratios and Metrics
Market cap in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| Current | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Dec '24 Dec 20, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Market Capitalization | 72 | 268 | 287 | 577 | 3,033 | - | |
| Market Cap Growth | -32.65% | -6.83% | -50.22% | -80.97% | - | - | |
| Enterprise Value | -64 | 38 | 65 | 259 | 2,798 | - | |
| Last Close Price | 1.30 | 4.27 | 6.04 | 12.45 | 71.55 | - | |
| PB Ratio | 0.46 | 1.13 | 1.47 | 2.02 | 14.29 | - | |
| P/TBV Ratio | 0.73 | 1.13 | 1.47 | 2.02 | 14.29 | - | |
| Debt / Equity Ratio | 0.12 | 0.07 | 0.01 | 0.01 | - | 0.02 | |
| Quick Ratio | 6.91 | 10.67 | 9.30 | 15.17 | 19.19 | 3.90 | |
| Current Ratio | 7.04 | 10.79 | 9.42 | 15.37 | 19.41 | 4.18 | |
| Return on Equity (ROE) | -66.64% | -56.33% | -47.97% | -44.85% | -49.67% | -178.26% | |
| Return on Assets (ROA) | -39.29% | -33.19% | -29.38% | -26.89% | -29.92% | -91.79% | |
| Return on Capital (ROIC) | -43.33% | -36.64% | -31.85% | -28.44% | -32.01% | -112.65% | |
| Earnings Yield | -183.82% | -45.50% | -40.16% | -19.35% | -1.88% | - | |
| FCF Yield | -150.34% | -41.29% | -30.18% | -14.87% | -1.54% | - | |
| Buyback Yield / Dilution | -35.27% | -27.41% | -2.87% | -269.03% | -647.86% | -18.93% | |
| Total Shareholder Return | -35.27% | -27.41% | -2.87% | -269.03% | -647.86% | -18.93% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.